Skip to content
healthcare.dev

Erlotinib

NDC 59651-531, Erlotinib, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
59651-531
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216342
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-531 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERLOTINIB HYDROCHLORIDE100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
59651-531-035965105310330 TABLET, FILM COATED in 1 BOTTLE (59651-531-03)
59651-531-10596510531101 BLISTER PACK in 1 CARTON (59651-531-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3ecafc1e-979a-4aff-a276-18fc0b110491

Use it

Look up 59651-531 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-531 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-531. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.